Verrica Pharmaceuticals Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VRCA research report →
About the company
Verrica Pharmaceuticals Inc. , a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts.
- CEO
- Jayson Rieger
- IPO
- 2018
- Employees
- 76
- HQ
- West Chester, PA, US
Price Chart
- Market Cap
- $65.35M
- P/E
- -3.94
- P/S
- 1.76
- P/B
- 4.07
- EV/EBITDA
- -4.07
- Div Yield
- 0.00%
- Gross Margin
- 89.52%
- Op Margin
- -36.39%
- Net Margin
- -47.97%
- ROE
- -1136.50%
- ROIC
- -58.02%
- Revenue
- $35.58M · 370.22%
- Net Income
- $-17,886,000 · 76.64%
- EPS
- $-1.68 · 88.63%
- Op Income
- $-11,939,000
- FCF YoY
- 71.08%
- 52W High
- $9.82
- 52W Low
- $3.28
- 50D MA
- $6.33
- 200D MA
- $5.96
- Beta
- 1.49
- Avg Volume
- 69.33K
Get TickerSpark's AI analysis on VRCA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 5, 26 | Eichenfield Lawrence | other | 16,000 |
| Jun 5, 26 | Nguyen Diem | other | 16,000 |
| Jun 5, 26 | PRYGOCKI MARK A SR | other | 16,000 |
| Jun 5, 26 | Rosenberg Noah L. | other | 233,840 |
| Jun 5, 26 | Zawitz David | other | 171,340 |
| Jun 5, 26 | Rieger Jayson | other | 512,269 |
| Jun 5, 26 | Corcoran Gavin | other | 16,000 |
| Nov 25, 25 | BKB Growth Investments, LLC | other | 224,719 |
| Nov 25, 25 | BKB Growth Investments, LLC | other | 0 |
| Nov 25, 25 | BKB Growth Investments, LLC | other | 224,719 |
Our VRCA coverage
Recent articles, reports, and earnings notes.
No research on VRCA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VRCA report →Similar companies
Peers in the same neighborhood.